Abstract

Some elderly citizens with a clinical diagnosis of type 2 diabetes had evidence of positive islet autoantibodies. We aimed to discover their islet autoantibody patterns and independent correlative factors that might lead to a better understanding of significance of islet autoimmunity in the progression of elderly diabetes. A total of 541 inpatients of clinically diagnosed type 2 diabetes aged 60 and over were recruited. Three islet autoantibodies including insulin autoantibody (IAA), islet cell antibody (ICA), and glutamic acid decarboxylase antibody (GADA) as well as clinical and biochemical characteristics were tested and collected in Huashan Hospital. Associations between these antibodies and clinical features were analyzed by Spearman correlation and binary logistic analyses. In our current study, total positive rate of islet autoantibodies (IAA, ICA, and GADA) was 35.67% with 26.62% for individual IAA, 5.55% for ICA, and 5.91% for GADA, in elderly with type 2 diabetes. None of combinations of such autoantibodies were observed, with the exception of IAA + ICA (0.74%, n = 4), IAA + GADA (1.48%, n = 8), and ICA + GADA (0.18%, n = 1). Compared with GADA negative group, patients in positive group tended to have lower level of fasting and postprandial C peptide, fasting blood glucose (FBG), and body mass index (BMI). After adjusted for the BMI, FBG, and postprandial C peptide, fasting C peptide seemed to be an independent factor related to GADA positivity (OR = 0.52, p = 0.02). As for patients with positive IAA, they were more likely to have insulin treatment with longer duration of diabetes, higher level of BMI, and lower level of postprandial C peptide. After adjusted for the duration of diabetes, BMI, and postprandial C peptide, insulin treatment was a significant predictor for IAA positivity (OR = 5.20, p < 0.0001). Furthermore, hs-CRP was positively related to ICA positivity, and hs-CRP appeared to be an independent indicator for ICA (OR = 3.43, p = 0.008). In elderly with type 2 diabetes, high prevalence rate of IAA was frequently accompanied with insulin treatment, while ICA and GADA were more closely associated with the systemic inflammation and beta-cell failure, respectively.

Highlights

  • Islet autoimmunity was the hallmark of classical type 1 diabetes, which distinguishes it from type 2 diabetes

  • There was rare combination of different autoantibodies observed in elderly diabetes patients, apart from insulin autoantibody (IAA) + islet cell antibody (ICA) (0.74%, n = 4), IAA + glutamic acid decarboxylase antibody (GADA) (1.48%, n = 8), and ICA + GADA (0.18%, n = 1)

  • Previous studies had indicated that a wide range of 4–17% of apparent type 2 diabetes had markers of islet autoimmunity as seen in type 1 diabetes [6, 18, 19]

Read more

Summary

Introduction

Islet autoimmunity was the hallmark of classical type 1 diabetes, which distinguishes it from type 2 diabetes. Accumulating evidences [2,3,4] had substantiated that a group of adult patients clinically diagnosed with type 2 diabetes exhibited positivity of autoantibodies as well. LADA was viewed as type 1.5 diabetes because of a combination of features of both type 2 diabetes, such as late-onset and non-insulin-requiring at diagnosis, and type 1 diabetes with positivity in islet autoantibodies [5]. The prevalence of islet autoantibodies was 52–74% in type 1 diabetes, while about 5% in type 2 diabetes and 1% in healthy volunteers [6, 7]. Some elderly citizens with a clinical diagnosis of type 2 diabetes had evidence of positive islet autoantibodies. We aimed to discover their islet autoantibody patterns and independent correlative factors that might lead to a better understanding of significance of islet autoimmunity in the progression of elderly diabetes

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call